These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7564810)

  • 1. Salbutamol in the treatment of asthma.
    Perrin-Fayolle M
    Lancet; 1995 Oct; 346(8982):1101. PubMed ID: 7564810
    [No Abstract]   [Full Text] [Related]  

  • 2. Formoterol induces tolerance to the bronchodilating effect of Salbutamol following methacholine-provocation test in asthmatic children.
    Adler A; Uziel Y; Mei-Zahav M; Horowitz I
    Pulm Pharmacol Ther; 2006; 19(4):281-5. PubMed ID: 16169761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bronchoprotective and bronchodilator effects of single doses of (S)-salbutamol, (R)-salbutamol and racemic salbutamol in patients with bronchial asthma.
    Ramsay CM; Cowan J; Flannery E; McLachlan C; Taylor DR
    Eur J Clin Pharmacol; 1999 Jul; 55(5):353-9. PubMed ID: 10456484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the dose response to levalbuterol with and without pretreatment with S-albuterol after methacholine-induced bronchoconstriction.
    Raissy HH; Harkins M; Esparham A; Kelly HW
    Pharmacotherapy; 2007 Sep; 27(9):1231-6. PubMed ID: 17723076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists.
    van der Woude HJ; Winter TH; Aalbers R
    Thorax; 2001 Jul; 56(7):529-35. PubMed ID: 11413351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regular inhaled salbutamol and airway responsiveness to allergen.
    Cockcroft DW; McParland CP; Britto SA; Swystun VA; Rutherford BC
    Lancet; 1993 Oct; 342(8875):833-7. PubMed ID: 8104272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duration of bronchoprotection of inhaled ipratropium against inhaled methacholine.
    Illamperuma C; Davis BE; Fenton ME; Cockcroft DW
    Ann Allergy Asthma Immunol; 2009 May; 102(5):438-9. PubMed ID: 19496252
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of single doses of inhaled lignocaine on FEV1 and bronchial reactivity in asthma.
    Harrison TW; Tattersfield AE
    Respir Med; 1998 Dec; 92(12):1359-63. PubMed ID: 10197230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time course of methacholine induced bronchoconstriction during drugs and spontaneous resolution.
    Mannino F; Anticoli S; De Luca A; Terzano C
    Allergol Immunopathol (Madr); 1996; 24(2):70-4. PubMed ID: 8933892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of regular salmeterol treatment on albuterol-induced bronchoprotection in mild asthma.
    Yates DH; Worsdell M; Barnes PJ
    Am J Respir Crit Care Med; 1997 Sep; 156(3 Pt 1):988-91. PubMed ID: 9310023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The structural basis of airways hyperresponsiveness in asthma.
    Stănescu DC
    J Appl Physiol (1985); 2006 Dec; 101(6):1812; author reply 1813. PubMed ID: 16931560
    [No Abstract]   [Full Text] [Related]  

  • 12. Rapid onset of tolerance to the bronchoprotective effect of salmeterol.
    Bhagat R; Kalra S; Swystun VA; Cockcroft DW
    Chest; 1995 Nov; 108(5):1235-9. PubMed ID: 7587422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The protective effect of salbutamol inhaled using different devices on methacholine bronchoconstriction.
    Giannini D; Di Franco A; Bacci E; Dente FL; Taccola M; Vagaggini B; Paggiaro P
    Chest; 2000 May; 117(5):1319-23. PubMed ID: 10807817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measuring the bronchial effect of bronchodilating drugs in healthy subjects after methacholine provocation. Salbutamol as a model drug.
    Seppälä OP; Iisalo E
    Eur J Clin Pharmacol; 1990; 39(6):559-63. PubMed ID: 2095342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of reducing the fine-particle mass of salmeterol from metered-dose inhalers on bronchodilatation and bronchoprotection against methacholine challenge: a randomized, placebo-controlled, double-blind, crossover study.
    Langley SJ; Allen D; McDonnell B; Wheeler N; Sharma RK; Sykes A; Woodcock A
    Clin Ther; 2005 Jul; 27(7):1004-12. PubMed ID: 16154479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the result of methacholine challenge accurate for assessing the bronchoprotective effects of long-acting beta-adrenergic bronchodilators?
    Bumbacea D; Diot P; Lamarie E
    Chest; 1996 Jul; 110(1):305-6. PubMed ID: 8681658
    [No Abstract]   [Full Text] [Related]  

  • 17. A twelve month comparison of salmeterol with salbutamol in asthmatic patients. European Study Group.
    Britton MG; Earnshaw JS; Palmer JB
    Eur Respir J; 1992 Oct; 5(9):1062-7. PubMed ID: 1426215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dependence of bronchoconstrictor and bronchodilator responses on thoracic gas compression volume.
    Pellegrino R; Antonelli A; Crimi E; Gulotta C; Torchio R; Dutto L; Pedersen OF; Brusasco V
    Respirology; 2014 Oct; 19(7):1040-5. PubMed ID: 25039769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-response protective effect of salbutamol on methacholine airway responsiveness using pressurized metered dose inhalers and Turbuhalers.
    Wong AG; O'Byrne PM; Lindbladh C; Inman MD; Stâhl E; Hargreave FE
    Can Respir J; 1998; 5(2):119-23. PubMed ID: 9707454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of oral salbutamol and pirbuterol on FEV1, heart rate and blood pressure in asthmatics.
    Willey RF; Grant IW; Pocock SJ
    Br J Clin Pharmacol; 1976 Aug; 3(4):595-600. PubMed ID: 22216500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.